Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01312116
Other study ID # Dnr 2007-0756
Secondary ID
Status Completed
Phase N/A
First received March 7, 2011
Last updated March 9, 2011
Start date January 2009
Est. completion date December 2010

Study information

Verified date March 2011
Source Linkoeping University
Contact n/a
Is FDA regulated No
Health authority Sweden: Regional Ethical Review Board
Study type Interventional

Clinical Trial Summary

The objective is to test if Internet-delivered cognitive behavior therapy (iCBT) or Internet-delivered psychodynamic therapy (iPDT) performs better for a population with generalized anxiety disorder (GAD), compared to a wait-list control condition.


Description:

This was a non-inferiority trial within the context of a parallel group study with unrestricted randomisation in 1:1:1 ratio conducted in Sweden. Outcome assessors were blind to treatment status.


Recruitment information / eligibility

Status Completed
Enrollment 81
Est. completion date December 2010
Est. primary completion date October 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- fulfill the diagnostic criteria for GAD according to DSM-IV

- have access to the Internet

- have good knowledge of the Swedish language

Exclusion Criteria:

- recent (during last 6 weeks) change in psychiatric medication

- presently in any other psychological treatment

- severe depression

- suicidal ideation

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
iCBT
Internet-delivered cognitive behavior therapy, 8 weeks
iPDT
Internet-delivered psychodynamic therapy, 8 weeks

Locations

Country Name City State
Sweden Linköping University Linköping Östergötland

Sponsors (2)

Lead Sponsor Collaborator
Linkoeping University Stockholm University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Penn State Worry Questionnaire (PSWQ) Change from baseline in anxiety symptoms to two weeks post treatment. Two weeks pre treatment to two weeks post treatment. No
Secondary Montgomery Åsberg Depression Rating Scale-Self Rated (MADRS-S) Change from baseline in depressive symptoms to two weeks post treatment. Two weeks pre treatment to two weeks post treatment Yes
Secondary Quality of Life Inventory (QOLI) Change from baseline in quality of life status to two weeks post treatment. Two weeks pre treatment to two weeks post treatment No
Secondary Beck Depression Inventory (BDI) Change from baseline in depressive symptoms to two weeks post treatment. Two weeks pre treatment to two weeks post treatment No
Secondary Beck Anxiety Inventory (BAI) Change from baseline in anxiety symptoms to two weeks post treatment. Two weeks pre treatment to two weeks post treatment No
Secondary Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness (TIC-P) Change from baseline in societal cost of illness to two weeks post treatment. Two weeks pre treatment to two weeks post treatment No
Secondary State Trait Anxiety Inventory (STAI) Change from baseline in anxiety symptoms to two weeks post treatment. Two weeks pre treatment to two weeks post treatment No
Secondary Generalized Anxiety Disorder Questionnaire IV (GAD-Q IV) Change from baseline in anxiety symptoms to two weeks post treatment. Two weeks pre treatment to two weeks post treatment No
See also
  Status Clinical Trial Phase
Terminated NCT03420456 - Transcranial Pulse Near-Infrared Light in Generalized Anxiety Disorder: a Placebo-Controlled Study N/A
Active, not recruiting NCT05530642 - An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel N/A
Withdrawn NCT02382224 - Worry Exposure for Generalized Anxiety Disorder N/A
Completed NCT02256566 - Cognitive Training for Mood and Anxiety Disorders N/A
Completed NCT02306356 - Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting N/A
Completed NCT01958788 - Testing Beliefs About Uncertainty in the Treatment of Generalized Anxiety Disorder N/A
Completed NCT01681329 - Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety Disorder N/A
Completed NCT01201967 - A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients Phase 4
Completed NCT01342120 - PHARMO Institute Seroquel Safety Study N/A
Completed NCT01337713 - Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD) N/A
Completed NCT01971203 - Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat N/A
Completed NCT01203293 - Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector Phase 1
Completed NCT00961298 - An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder Phase 4
Terminated NCT01244711 - Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines Phase 4
Completed NCT00744627 - Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults. Phase 3
Completed NCT00711737 - Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months N/A
Completed NCT00525226 - Evaluating the Effects of Stress in Pregnancy N/A
Completed NCT00537615 - An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers Phase 1
Completed NCT00515242 - Therapeutic Massage for Generalized Anxiety Disorder Phase 1/Phase 2
Completed NCT00620776 - Combined Treatment for Generalized Anxiety Disorder (GAD) Phase 2